Lindsey te Brake
In august 2012 Lindsey started her PhD at the Radboud university medical center, in which she studied the molecular mechanisms underlying (un)wanted transporter mediated drug-drug interactions and assessed the pharmacokinetics and drug-related adverse effects of TB drugs as part of multiple drug therapy in TB patients. For the pharmacokinetic studies she spent considerable time at Universitas Padjadjaran and Hasan Sadikin hospital in Bandung, Indonesia, an important partner in tuberculosis research for the Radboudumc. After finishing her PhD, in January 2017, Lindsey has continued her work as a postdoctoral researcher, studying potential new and safe drug regimens against tuberculous meningitis. Furthermore, she is working as scientific project manager for PanACEA-II (Pan-African Consortium for the Evaluation of Antituberculosis Antibiotics), focusing on the HIGHRIF1-study, trial and consortium coordination, drug management, pharmacology, and providing scientific support.